FIM-001
Non-small cell lung cancer, Pancreatic cancer
DiscoveryActive
Key Facts
About FIMECS
Japanese biotech developing targeted protein degradation drugs for undruggable oncology targets using its proprietary RaPPIDS™ platform.
View full company profile